Drugs for Huntington Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 174)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
2 |
|
Memantine |
Approved, Investigational |
Phase 4 |
|
41100-52-1, 19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
1,3-DIMETHYLAMINOADAMANTANE
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
AKATINOL
Axura
Axura®|Ebixa®|Namenda®
D-145
DMAA
DRG-0267
Ebixa
Exiba
FP-01
Lundbeck brand OF memantine hydrochloride
|
MARIXINO
Memantin
Memantina
Memantina [INN-Spanish]
MEMANTINE
Memantine [INN]
MEMANTINE HCL
Memantine hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
Namenda
NAMENDA XR
NEMDATINE
NSC-102290
SUN-Y7017
VALIOS
|
|
3 |
|
Tetrabenazine |
Approved, Investigational |
Phase 4 |
|
58-46-8 |
6018 |
Synonyms:
1,2,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one
2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11BH-benzo[a]quinolizine
2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine
Cambridge laboratories brand OF tetrabenazine
Nitoman
Nitoman®|Revocon®|Ro-19569|TBZ
NSC-169886
Orphan brand OF tetrabenazine
Regulin
REVOCON
Ro 1-9569
RO-19569
RO-1-9569
Roche brand OF tetrabenazine
Rubigen
|
Shire brand OF tetrabenazine
TBZ
TETMODIS
Tetra benazin
TETRABENAZINA
Tetrabenazina [inn-spanish]
Tetrabenazine
Tetrabenazine orphan brand
TETRABENAZINUM
Tetrabenazinum [inn-latin]
Tetrabenzaine
Tetrabenzine
Xenazine
XENAZINE 25
|
|
4 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
5 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
6 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
7 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
8 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
9 |
|
Cysteamine |
Approved, Investigational |
Phase 2, Phase 3 |
|
60-23-1 |
6058 |
Synonyms:
(2-Mercaptoethyl)amine
2 Aminoethanethiol
2-Amino-1-ethanethiol
2-AMINOETHANE-1-THIOL
2-Aminoethanethiol
2-AMINO-ethanethiol
2-Aminoethyl mercaptan
2-Mercaptoethanamine
35S-Labeled cysteamine
Aminoethyl mercaptan
b-Aminoethanethiol
b-Aminoethylthiol
Becaptan
beta Mercaptoethylamine
beta-Aminoethanethiol
beta-Aminoethylthiol
beta-MEA
beta-Mercaptoethylamine
Bitartrate, cysteamine
b-MEA
b-Mercaptoethylamine
CASH
CI-9148
Cisteamina
Cystagon
Cystavision
Cysteamide
Cysteamin
Cysteamine
Cysteamine bitartate
Cysteamine bitartrate
Cysteamine dihydrochloride
Cysteamine hydrobromide
Cysteamine hydrochloride
Cysteamine maleate (1:1)
|
Cysteamine tartrate
Cysteamine tartrate (1:1)
Cysteamine tosylate
Cysteamine, 35S labeled
Cysteamine, 35S-labeled
Cysteaminium
Cysteinamine
Decarboxycysteine
Dihydrochloride, cysteamine
Ethanethiolamine
Hydrobromide, cysteamine
Hydrochloride, cysteamine
L-1573
Lambraten
Lambratene
MEA
Mecramine
Mercamin
Mercamine
Mercaptamin
Mercaptamina
Mercaptamine
Mercaptaminum
Mercaptoethylamine
Merkamin
NSC-647528
PROCYSBI
Riacon
Tartrate, cysteamine
Thioethanolamine
Tosylate, cysteamine
Β-aminoethanethiol
Β-aminoethylthiol
Β-mea
Β-mercaptoethylamine
|
|
10 |
|
Olanzapine |
Approved, Investigational |
Phase 3 |
|
132539-06-1 |
135398745 4585 |
Synonyms:
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-B][1,5]BENZODIAZEPINE
ARKOLAMYL
Lanzac
LY170053
LY-170053
LY-170053|Zyprexa®
Olansek
OLANZAPIN
Olanzapina
|
OLANZAPINE
Olanzapine pamoate
Olanzapinum
Symbyax
ZALASTA
Zolafren
Zydis
Zyprexa
Zyprexa intramuscular
Zyprexa zydis
|
|
11 |
|
Fluoxetine |
Approved, Vet_approved |
Phase 3 |
|
54910-89-3 |
3386 |
Synonyms:
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
Adofen
Animex-On
Deprex
Eufor
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
FLUOXETINE
Fluoxétine
Fluoxetine Hcl
Fluoxetine hydrochloride
|
Fluoxetinum
Fluoxetinum [INN-Latin]
Fluval
Fontex
Foxetin
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
NSC-283480
Portal
Prozac
Prozac Weekly
Prozac®
Pulvules
Reneuron
Sarafem
Symbyax
|
|
12 |
|
Paroxetine |
Approved, Investigational |
Phase 3 |
|
61869-08-7 |
43815 |
Synonyms:
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(−)-(3S,4R)-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
Acetate, paroxetine
Anhydrous, paroxetine hydrochloride
Aropax
BRL-29060
Hemihydrate paroxetine hydrochloride
Hemihydrate, paroxetine hydrochloride
Hydrochloride anhydrous, paroxetine
Hydrochloride hemihydrate, paroxetine
Hydrochloride, hemihydrate paroxetine
Hydrochloride, paroxetine
Maleate, paroxetine
Paroxetina
Paroxetina [INN-Spanish]
PAROXETINE
Paroxetine acetate
|
Paroxetine Hcl
Paroxetine hydrochloride
paroxetine hydrochloride (anhydrous or hemihydrate)|Paxil®|Seroxat®
Paroxetine hydrochloride anhydrous
Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride, hemihydrate
Paroxetine maleate
Paroxetine, cis-(-)-isomer
Paroxetine, cis-(+)-isomer
Paroxetine, trans-(+)-isomer
Paroxetinum
Paroxetinum [INN-Latin]
Paxil
PAXIL [AS HYDROCHLORIDE]
Paxil CR
PEXEVA
Seroxat
Seroxat CR
|
|
13 |
|
Riluzole |
Approved, Investigational |
Phase 3 |
|
1744-22-5 |
5070 |
Synonyms:
2 Amino 6 trifluoromethoxybenzothiazole
2-Amino-6-trifluoromethoxybenzothiazole
Aventis behring brand OF riluzole
Aventis brand OF riluzole
BHV-0223
Impax brand OF riluzole
Rhone poulenc rorer brand OF riluzole
Rhone-poulenc rorer brand OF riluzole
Rilutek
|
Rilutek®|RP-54274|Tiglutik® (thickened oral suspension)
RILUZOL
RILUZOLE
Riluzole aventis brand
Riluzole impax brand
RILUZOLUM
RP-54274
TEGLUTIK
TIGLUTIK KIT
|
|
14 |
|
Minocycline |
Approved, Investigational |
Phase 2, Phase 3 |
|
10118-90-8, 13614-98-7 |
54675783 5281021 |
Synonyms:
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
ACNAMINO
AKNEMIN
AKNEMIN 50
Alti-Minocycline
Apo-Minocycline
ARESTIN
BLEMIX 100
BLEMIX 50
CYCLOMIN
DENTOMYCIN
DYNACIN
Gen-Minocycline
KLINOMYCIN
MINO
Minociclina
Minociclina [INN-Spanish]
Minociclinum
MINOCIN
|
MINOCIN 50
MINOCIN MR
MINOCYCLIN
MINOCYCLINE
MINOCYCLINE HCL
MINOCYCLINE HYDROCHLORIDE
MINOCYCLINUM
Minocyclinum [INN-Latin]
Minocyn
MINOGAL
MINOLIRA
Minomycin
Novo-Minocycline
NSC-141993
SEBOMIN
SEBREN MR
SOLODYN
VECTRIN
XIMINO
|
|
15 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 3 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
16 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 3 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
17 |
|
Dextromethorphan |
Approved |
Phase 3 |
|
125-71-3 |
5362449 5360696 |
Synonyms:
(-)-3-Methoxy-17-methylmorphinan
(-)-3-Methoxy-N-methylmorphinan
(+)-DEXTROMETHORPHAN
(9S,13S,14S)-3-METHOXY-17-METHYLMORPHINAN
Antussan
Balminil DM
Balminil DM Children
Bayer select flu relief
Bayer select head & chest cold
Bayer select night time cold
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
Calmylin #1
Canfodion
Cerose-DM
Chloraseptic DM
Contac day & night cold/flu day caplets
Contac jr. non-drowsy formula
Contac nighttime cold medicine
Contac severe cold formula maximum strength
Contac severe cold formula non-drowsy
Coricidin syrup
Cosylan
Cough-X
Creo-Terpin
Delsym
Delsym Cough Formula
delta-Methorphan
Demorphan
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [Dcit]
DEX
DEXTROMETHORFAN
Dextromethorfan [Czech]
DEXTROMETHORPHAN
Dextromethorphan bromhydrate
Dextromethorphan bromide
Dextromethorphan hydrobromide
Dextromethorphan hydrobromide monohydrate
Dextromethorphan hydrobromide oros tablets
Dextromethorphan hydrobromide, (+-)-isomer
Dextromethorphan hydrobromide, monohydrate
Dextromethorphan hydrochloride
Dextromethorphan, (+-)-isomer
DEXTROMÉTHORPHANE
DEXTROMETHORPHANUM
DEXTROMETORFANO
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dexyromethorphan
Diabe-Tuss DM Syrup
Dimacol
DIMETANE-DX
Dimetapp DM
DM
D-Methorphan
D-Methorphan hydrobromide
Dormetan
Dormethan
Drixoral cough
Drixoral cough & congestion
Drixoral cough & sore throat
DXM
|
Endotussin-NN
Endotussin-NN pediatric
Hihustan M.
Hold
Hold DM
Hydrobromide, dextromethorphan
Hydrochloride, dextromethorphan
Koffex DM
L-3-Methoxy-17-methylmorphinan
Levomethorphan
Levomethorphan [Ban:Dcf:Inn]
Levomethorphane
Levomethorphane [INN-French]
Levomethorphanum
Levomethorphanum [INN-Latin]
Levometorfano
Levometorfano [INN-Spanish]
L-Methorphan
Medicon
Methorate
Methorate Hydrobromide
Methorphan
Metrorat
Naldecon-DX
Novahistex DM
Novahistine DM
Ornex severe cold formula
Orthoxicol
PediaCare 1
PediaCare cough-cold formula
Pertussin CS Children's Strength
Pertussin DM Extra Strength
Prestwick_686
Racemethorphan
Robitussin CF
Robitussin cold & cough
Robitussin cough calmers
Robitussin DM
Robitussin maximum strength cough
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin pediatric cough
Robitussin pediatric cough & cold
Robitussin Pediatric Cough Suppressant
Robitussin pediatric night relief
Romilar
Rondec DM
Ru-tuss expectorant
St. joseph cough syrup
Sucrets 4 Hour Cough Suppressant
Sudafed cough syrup
Triaminic
Triaminic DM Long Lasting for Children
Trind-DM
Trocal
Tusilan
Tussade
Tussar DM
Tussi-organidin
Tussi-organidin DM NR
Tussi-organidin DM-S NR
Tylenol cold and flu multi-symptom
Tylenol cold and flu no drowsiness
Tylenol cold no drowsiness
Tylenol cough + decongestant liquid
Tylenol cough liquid
Tylenol flu no drowsiness gelcaps
Vicks 44 Cough Relief
Viro-med
Δ-methorphan
|
|
18 |
|
Quinidine |
Approved, Investigational |
Phase 3 |
|
56-54-2, 130-95-0, 804-63-7 |
1065 441074 3034034 8549 |
Synonyms:
(−)-quinine
(-)-Quinine
(+)-Quinidine
(8R,9S)-Quinidine
(8S,9R)-Quinine
(R)-(−)-quinine
(R)-(-)-Quinine
(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-METHOXY-QUINOLIN-4-YL)-((2S,5S)-5-VINYL-1-AZA-BICYCLO[2.2.2]OCT-2-YL)-METHANOL
(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-METHOXY-4-QUINOLYL)-[(2R,4S,5R)-5-VINYL-2-QUINUCLIDINYL]METHANOL
(S)-(6-METHOXY-4-QUINOLYL)-[(2R,4S,5R)-5-VINYLQUINUCLIDIN-2-YL]METHANOL
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
(S)-[(4S,5R,7R)-5-ETHENYL-1-AZABICYCLO[2.2.2]OCTAN-7-YL]-(6-METHOXYQUINOLIN-4-YL)METHANOL
6-Methoxy-a-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6'-Methoxycinchonidine
6'-Methoxycinchonine
6-Methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
a-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Adaquin
Aflukin
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Alphapharm brand OF quinine sulfate
Apo quinidine
Apo-quinidine
Apotex brand OF quinidine sulfate
Aventis brand OF quinine bisulfate
beta-Quinine
Biquin Durules
Biquinate
Bisulfate, quinine
b-Quinine
Cardioquin
Chinidin
Chinidinum
Chinin
Chinine
Chininum
CIN-quin
Coccinine
Coco-Quinine
Conchinin
Conchinine
Conquinine
Duraquin
Fawns and mcallan brand OF quinidine sulfate
Fawns and mcallan brand OF quinine bisulfate
Fawns and mcallan brand OF quinine sulfate
Foy brand OF quinine sulfate
GNF-PF-506
GNF-Pf-506|Qualaquin®|Quinate®|quinine bisulphate|quinine sulfate
Hoechst brand OF quinine sulfate
Hydrochloride, quinine
Innotech brand OF quinine hydrochloride
Kinidin
Lafran brand OF quinine hydrochloride
Legatrim
|
Myoquin
Nelson brand OF quinidine sulfate
Novoquinidin
NSC-192949
Odan brand OF quinine sulfate
Pitayin
Pitayine
Plough brand OF quinine sulfate
Prosana brand OF quinine bisulfate
QUALAQUIN
Quinact
QUINAGLUTE
Quinaglute Dura-Tabs
Quinaglute®|Quinidex®|quinidine hydrochloride
Quinalan
Quinamm
QUINATE
Quinatime
Quinbisan
Quinbisul
Quincardine
Quindan
Quindine
Quinicardine
Quinidex
Quinidex Extentabs
Quinidina
QUINIDINE
Quinidine Gluconate
QUINIDINE HYDROCHLORIDE
Quinidine sulfate
Quinimax
Quinina
QUININE
Quinine bisulfate
QUININE BISULPHATE
Quinine Dab
Quinine hydrochloride
Quinine lafran
Quinine sulfate
Quinine sulphate
Quinine, anhydrous
Quinineanhydrous
Quinine-odan
Quinoctal
Quinoline alkaloid
Quinora
Quin-Release
Quinson
Quinsul
Robins brand OF quinidine sulfate
Strema
Sulfate, quinidine
Sulfate, quinine
Sulphate, quinine
Surquina
WR297608
Α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
Β-quinine
|
|
19 |
|
Metformin |
Approved |
Phase 3 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
20 |
|
Ubidecarenone |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
303-98-0 |
5281915 |
Synonyms:
(all-e)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
(all-e)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-cyclohexadiene-1,4-dione
2-((all-e)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2,3-Dimethoxy-5-methyl-6-decaprenylbenzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiene-1,4-dione
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone
4-Ethyl-5-fluoropyrimidine
Adelir
all-trans-Ubiquinone
API 31510
API-31510
Aqua Q 10l10
Aqua Q10
Bio-quinon
Bio-quinone Q10
Coenzyme Q10
Coenzyme Q-10
CO-Enzyme Q10
CoQ
CoQ 10
CoQ10
Ensorb
Kaneka Q10
|
Kudesan
Li-Q-sorb
Liquid-Q
Neuquinon
Neuquinone
NSC-140665
NSC-140865
PureSorb Q 40
Q
Q 10AA
Q 199
Q10
Q-Gel
Q-Gel 100
Q-Ter
Ubidecarenone
UBIDECARENONE FOR SYSTEM SUITABILITY
Ubiquinone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
UBIQUINONE-10
Unbiquinone
Unispheres Q 10
|
|
21 |
|
Creatine |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
57-00-1 |
586 |
Synonyms:
((Amino(imino)methyl)(methyl)amino)acetate
((Amino(imino)methyl)(methyl)amino)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(a-Methylguanido)acetate
(a-Methylguanido)acetic acid
(N-Methylcarbamimidamido)acetate
(N-Methylcarbamimidamido)acetic acid
(Α-methylguanido)acetate
(Α-methylguanido)acetic acid
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetate
alpha-Methylguanidino acetic acid
a-Methylguanidino acetate
a-Methylguanidino acetic acid
Cosmocair C 100
Creatin
Creatine
|
Creatine (8CI)
Creatine hydrate
Creatine, hydrate
Kreatin
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-methylglycine
N-(Aminoiminomethyl)-N-methyl-glycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
NSC-8752
Phosphagen
Pyrolysate
Α-methylguanidino acetate
Α-methylguanidino acetic acid
|
|
22 |
|
Tiapride Hydrochloride |
|
Phase 3 |
|
|
|
23 |
|
Platelet Aggregation Inhibitors |
|
Phase 3 |
|
|
|
24 |
|
Eicosapentaenoic acid ethyl ester |
|
Phase 3 |
|
|
3298 |
Synonyms:
AMR-101
Eicosapentaenoate ethyl ester
Epadel
Ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Ethyl all-cis-5,8,11,14,17-icosapentaenoate
Ethyl eicosapentaenoate
Ethyl eicosapentaenoic acid
|
Ethyl icosa-5,8,11,14,17-pentaenoic acid
Ethyl icosapentaenoate
Ethyl-eicosapentaenoic acid
Ethyl-epa
Icosapent ethyl
Vascepa
|
|
25 |
|
Omega 3 Fatty Acid |
|
Phase 3 |
|
|
|
26 |
|
Neuroprotective Agents |
|
Phase 3 |
|
|
|
27 |
|
Anticonvulsants |
|
Phase 3 |
|
|
|
28 |
|
Anti-Bacterial Agents |
|
Phase 2, Phase 3 |
|
|
|
29 |
|
Anti-Arrhythmia Agents |
|
Phase 3 |
|
|
|
30 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 3 |
|
|
|
31 |
|
Antitussive Agents |
|
Phase 3 |
|
|
|
32 |
|
Adrenergic Antagonists |
|
Phase 3 |
|
|
|
33 |
|
Adrenergic alpha-Antagonists |
|
Phase 3 |
|
|
|
34 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
35 |
|
Sodium Channel Blockers |
|
Phase 3 |
|
|
|
36 |
|
Quinidine gluconate |
|
Phase 3 |
|
|
|
Synonyms:
DURAQUIN
QUINACT
QUINAGLUTE
|
QUINALAN
QUINATIME
QUINIDINE GLUCONATE
|
|
37 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
38 |
|
Antimalarials |
|
Phase 3 |
|
|
|
39 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 3 |
|
|
|
40 |
|
Muscarinic Antagonists |
|
Phase 3 |
|
|
|
41 |
|
Cholinergic Antagonists |
|
Phase 3 |
|
|
|
42 |
|
Cholinergic Agents |
|
Phase 3 |
|
|
|
43 |
|
Diuretics, Potassium Sparing |
|
Phase 3 |
|
|
|
44 |
|
Biguanides |
|
Phase 3 |
|
|
|
45 |
|
Hypoglycemic Agents |
|
Phase 3 |
|
|
|
46 |
|
Ubiquinone |
|
Phase 3 |
|
|
|
47 |
|
Trace Elements |
|
Phase 3 |
|
|
|
48 |
|
Micronutrients |
|
Phase 3 |
|
|
|
49 |
|
Vitamins |
|
Phase 3 |
|
|
|
50 |
|
Amantadine |
Approved |
Phase 2 |
|
768-94-5 |
2130 |
Synonyms:
1 Aminoadamantane
1-Adamantanamine
1-Adamantylamine
1-Aminoadamantane
AbZ brand OF amantadine hydrochloride
Adamantamine
Adamantanamine
Adamantylamine
Adekin
ADS-5102|Gocovri®|Symadine®|Symmetrel®
AL, amantadin
Aliud brand OF amantadine sulfate
Alliance brand OF amantadine hydrochloride
Aman
Amanta
Amanta hci azu
Amanta sulfate azu
Amantadin al
Amantadin azu
Amantadin neuraxpharm
Amantadin ratiopharm
Amantadin stada
Amantadina
Amantadina juventus
Amantadina llorente
AMANTADINE
Amantadine base
Amantadine HCL
Amantadine hydrochloride
Amantadine sulfate
Amantadinneuraxpharm
Amantadin-neuraxpharm
Amantadinratiopharm
Amantadin-ratiopharm
Amantadinum
Amanta-hci-azu
AmantaHCIAZU
Amantasulfateazu
Amanta-sulfate-azu
Amantidine
Aminoadamantane
Amixx
AZU, amantadin
Azupharma brand OF amantadine hydrochloride
Azupharma brand OF amantadine sulfate
Cerebramed
Ciba geigy brand OF amantadine hydrochloride
Ciba-geigy brand OF amantadine hydrochloride
Desitin brand OF amantadine hydrochloride
Du pont brand OF amantadine hydrochloride
|
Endantadine
endo Brand OF amantadine hydrochloride
Gen amantadine
Gen-amantadine
GenAmantadine
Genpharm brand OF amantadine hydrochloride
Hexal brand OF amantadine sulfate
Hormosan brand OF amantadine sulfate
Hydrochloride, amantadine
Infecto flu
Infecto-flu
InfectoFlu
Infectopharm brand OF amantadine hydrochloride
Infex
Juventus brand OF amantadine hydrochloride
Juventus, amantadina
Krewel brand OF amantadine hydrochloride
Llorente brand OF amantadine hydrochloride
Llorente, amantadina
Mantadine
Mantadix
Merz brand OF amantadine sulfate
Midantan
Neuraxpharm brand OF amantadine sulfate
Neuro hexal brand OF amantadine sulfate
Novartis brand OF amantadine hydrochloride
NSC-341865
Orion brand OF amantadine hydrochloride
Pharmascience brand OF amantadine hydrochloride
Pk-Merz
PMS Amantadine
PMSAmantadine
PMS-Amantadine
Ratiopharm brand OF amantadine hydrochloride
Solvay brand OF amantadine hydrochloride
Stada brand OF amantadine hydrochloride
Stada brand OF amantadine sulfate
Stada, amantadin
Sulfate, amantadine
Symadine
Symmetrel
TCMDC-125869
Thiemann brand OF amantadine hydrochloride
Tregor
Tricyclo[3.3.1.1(3,7)]decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-ylamine
Tricyclo[3.3.1.1(3,7)]decane-1-amine
Viregyt
Virosol
Wiregyt
|
|
Interventional clinical trials:
(show top 50)
(show all 221)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Effect of Tetrabenazine on Stroop Interference in Huntington Disease |
Completed |
NCT01834911 |
Phase 4 |
Tetrabenazine withdrawal |
2 |
A Pilot Study of Memantine for Cognitive and Behavioral Dysfunction in Huntington's Disease" |
Completed |
NCT00652457 |
Phase 4 |
Memantine |
3 |
A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) |
Recruiting |
NCT02509793 |
Phase 4 |
Tetrabenazine |
4 |
Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103) |
Unknown status |
NCT02101957 |
Phase 2, Phase 3 |
RP103;Placebo |
5 |
Neuroleptic and Huntington Disease. Comparison of : Olanzapine, la Tetrabenazine and Tiapride. A Multicentric, Randomised, Controlled Study. |
Completed |
NCT00632645 |
Phase 3 |
Olanzapine;Xenazine;Tiapridal |
6 |
A Multi-center, North American, Randomized, Double-blind, Parallel Group Study Comparing Three Doses of ACR16 Versus Placebo for the Symptomatic Treatment of Huntington Disease (HART) |
Completed |
NCT00724048 |
Phase 2, Phase 3 |
ACR16 10 mg;ACR16 22.5 mg;ACR16 45 mg |
7 |
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease |
Completed |
NCT01897896 |
Phase 3 |
SD-809 |
8 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease |
Completed |
NCT04102579 |
Phase 3 |
Valbenazine;Placebo |
9 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Dimebon in Patients With Mile-to-Moderate Huntington Disease |
Completed |
NCT00920946 |
Phase 3 |
Dimebon |
10 |
A Randomized Double-Blind, Placebo-Controlled Study of SD-809 Extended Release for the Treatment of Chorea Associated With Huntington Disease |
Completed |
NCT01795859 |
Phase 3 |
SD-809;Placebo |
11 |
A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's Disease |
Completed |
NCT00146211 |
Phase 3 |
Ethyl-EPA (Miraxion™) |
12 |
A Phase III Multicenter, Double-Blind, Parallel-Group, Placebo Controlled Study to Measure the Effect of Riluzole 50 mg b.i.d. Over a Period of Three Years on the Progression of Huntington's Disease |
Completed |
NCT00277602 |
Phase 3 |
Riluzole |
13 |
A Multi-Center, Double-Blind, Pilot Study of Minocycline in Huntington's Disease |
Completed |
NCT00277355 |
Phase 2, Phase 3 |
minocycline;Matching placebo |
14 |
A Multicentre, Multinational, Randomized, Double-blind, Parallel-group Study Comparing ACR16 Versus Placebo for the Symptomatic Treatment of Huntington's Disease |
Completed |
NCT00665223 |
Phase 3 |
ACR16;Placebo |
15 |
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease |
Completed |
NCT03761849 |
Phase 3 |
RO7234292;Placebo |
16 |
A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea |
Completed |
NCT00219804 |
Phase 3 |
tetrabenazine or placebo |
17 |
Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease |
Recruiting |
NCT04713982 |
Phase 2, Phase 3 |
Deutetrabenazine |
18 |
Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease |
Recruiting |
NCT04400331 |
Phase 3 |
Valbenazine |
19 |
Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease |
Recruiting |
NCT03854019 |
Phase 3 |
Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg);Placebo |
20 |
"Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Metformin, an Activator of AMPK, on Cognitive Measures of Progression in Huntington's Disease Patients" |
Recruiting |
NCT04826692 |
Phase 3 |
Metformin;Placebo |
21 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients With Early Stage of Huntington Disease |
Active, not recruiting |
NCT04556656 |
Phase 3 |
Pridopidine;Placebo |
22 |
An Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Intrathecally Administered RO7234292 (RG6042) in Patients With Huntington's Disease |
Active, not recruiting |
NCT03842969 |
Phase 3 |
RO7234292 (RG6042) |
23 |
Clinical Extension Study for Assessing the Safety and Efficacy of the Intravenous Administration of Cellavita-HD in Huntington's Disease Patients Who Participated in the ADORE-DH Study. |
Active, not recruiting |
NCT04219241 |
Phase 2, Phase 3 |
|
24 |
HORIZON-Plus: An Open-Label Extension of the HORIZON Protocol (DIM20) Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease |
Terminated |
NCT01085266 |
Phase 3 |
Dimebon (latrepirdine) |
25 |
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) |
Terminated |
NCT00712426 |
Phase 3 |
Creatine Monohydrate;Placebo |
26 |
Coenzyme Q10 in Huntington's Disease (HD) |
Terminated |
NCT00608881 |
Phase 3 |
coenzyme Q10 |
27 |
Safety and Efficacy of Bone Marrow Derived MNCs for the Treatment of Huntingtons Chorea. It is Self Funded (Patients' Own Funding) Clinical Trial |
Unknown status |
NCT01834053 |
Phase 1, Phase 2 |
|
28 |
Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease |
Completed |
NCT01882062 |
Phase 2 |
Triheptanoin 1g/kg/day |
29 |
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease |
Completed |
NCT01590888 |
Phase 2 |
PBT2;Placebo |
30 |
A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease; a Phase IIb Study |
Completed |
NCT01458470 |
Phase 2 |
Memantine |
31 |
Creatine Safety and Tolerability in Premanifest HD: PRECREST |
Completed |
NCT00592995 |
Phase 2 |
Creatine monohydrate;Placebo |
32 |
Multicentric Intracerebral Grafting in Huntington's Disease |
Completed |
NCT00190450 |
Phase 2 |
|
33 |
Dose-Response Evaluation of the Investigational Product Cellavita HD After Intravenous Administration in Patients With Huntington's Disease |
Completed |
NCT03252535 |
Phase 2 |
|
34 |
A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease |
Completed |
NCT02453061 |
Phase 2 |
Triheptanoin oil;Placebo |
35 |
A Randomized, Placebo-Controlled Pilot Study in Huntington's Disease (CIT-HD) |
Completed |
NCT00271596 |
Phase 2 |
20mg daily citalopram;Placebo |
36 |
Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study |
Completed |
NCT00368849 |
Phase 2 |
atomoxetine;Matching Placebo |
37 |
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease The ETON-Study - A Randomized, Double-blind, Stratified, Placebo-controlled Prospective Investigator Initiated Multicenter Trial - |
Completed |
NCT01357681 |
Phase 2 |
(2)-epigallocatechin-3-gallate (EGCG);Placebo |
38 |
A Multi-Center, North American, Open-Label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington's Disease (Open-HART). |
Completed |
NCT01306929 |
Phase 2 |
pridopidine |
39 |
A Phase 2a Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease |
Completed |
NCT04514367 |
Phase 2 |
ANX005 |
40 |
An Open-Label Extension Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139) |
Completed |
NCT03342053 |
Phase 2 |
RO7234292 (RG6042) |
41 |
Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage Huntington's Disease |
Completed |
NCT03306888 |
Phase 1, Phase 2 |
|
42 |
A Randomized, Double-blind, Placebo-controlled Prospective Crossover Trial Investigating the Efficacy and Safety of the Treatment With Bupropion in Patients With Apathy in Huntington's Disease |
Completed |
NCT01914965 |
Phase 2 |
Bupropion;Placebo |
43 |
A Phase 2, Dose-Finding, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study, Evaluating the Safety and Efficacy of Pridopidine 45, 67.5, 90, and 112.5 mg Twice-Daily vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease |
Completed |
NCT02006472 |
Phase 2 |
Pridopidine |
44 |
A Multi-Center, Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon in Subjects With Huntington's Disease |
Completed |
NCT00497159 |
Phase 2 |
Dimebon |
45 |
A Multicenter, Phase 1-2A, Open-Label, Dosage-Escalation and Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon in Subjects With Huntington's Disease |
Completed |
NCT00387270 |
Phase 1, Phase 2 |
Dimebon |
46 |
Minocycline Dosing and Safety in Huntington's Disease |
Completed |
NCT00029874 |
Phase 1, Phase 2 |
Minocycline |
47 |
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 443139 in Patients With Early Manifest Huntington's Disease |
Completed |
NCT02519036 |
Phase 1, Phase 2 |
ISIS 443139 10 mg;ISIS 443139 30 mg;ISIS 443139 60 mg;ISIS 443139 90 mg;ISIS 443139 120 mg |
48 |
An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects With Huntington's Disease (HD) |
Completed |
NCT02507284 |
Phase 2 |
SRX246;Placebo |
49 |
A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease |
Completed |
NCT00920699 |
Phase 2 |
CoQ10 |
50 |
A Phase 2, Multi-center, Randomized, Double-blind, Placebo Controlled Study in Subjects With Late Prodromal and Early Manifest Huntington's Disease to Assess the Safety, Tolerability, pk, and Efficacy of Pepinemab |
Completed |
NCT02481674 |
Phase 2 |
VX15/2503;Placebo |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Baclofen
coenzyme Q10
|
Perphenazine
Pimozide
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Huntington Disease:
Embryonic/Adult Cultured Cells Related to Huntington Disease:
|